SCHEMBL9833536

SCHEMBL9833536

CCCC(=O)Nc1nc2cc3c(cc2[nH]1)NC(=O)C3(C)C

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NPC1 O15118 4/20 0.45
RAB9A P51151 4/20 0.45
SMN1; SMN2 Q16637 3/20 0.45
ALDH1A1 P00352 1/20 0.45
SPHK2 Q9NRA0 1/20 0.44
SPHK1 Q9NYA1 1/20 0.44
PDE4A P27815 1/20 0.43
PDE4B Q07343 1/20 0.43
PDE4C Q08493 1/20 0.43
PDE4D Q08499 1/20 0.43
PDE3B Q13370 1/20 0.43
PDE3A Q14432 1/20 0.43
AURKA O14965 1/20 0.42
AURKB Q96GD4 1/20 0.42
ABL1 P00519 1/20 0.39
MAPT P10636 1/20 0.38
LMNA P02545 4/20 0.37
HIF1A Q16665 2/20 0.37
CYP1A2 P05177 2/20 0.37
MAPK1 P28482 2/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9835322 0.91 PDE4A (0.45) NPC1RAB9ASMN1; SMN2ALDH1A1SPHK2
SCHEMBL9834452 0.84 AURKA (0.49) SMN1; SMN2PDE4APDE4BPDE4CPDE4D
SCHEMBL9834995 0.78 PDE4A (0.55) NPC1RAB9ASMN1; SMN2PDE4APDE4B
SCHEMBL2489471 0.76 PDE3B (0.48) PDE4APDE4BPDE4CPDE4DPDE3B
SCHEMBL10558334 0.75 RAB9A (0.58) NPC1RAB9ASMN1; SMN2MAPTLMNA
SCHEMBL9835173 0.75 PDE3B (0.54) PDE4APDE4BPDE4CPDE4DPDE3B
SCHEMBL9834410 0.75 PDE4A (0.46) NPC1RAB9ASMN1; SMN2PDE4APDE4B
SCHEMBL9835632 0.74 KMT2A (0.50) ALDH1A1PDE4APDE4BPDE4CPDE4D
SCHEMBL9835346 0.74 PDE3B (0.51) PDE4APDE4BPDE4CPDE4DPDE3B
SCHEMBL10662905 0.73 PRKAG1 (0.55) ALDH1A1PDE4APDE4BPDE4CPDE4D

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0214592-B1 PYRROLOBENZIMIDAZOLES, PROCESS FOR THEIR PREPARATION AND MEDICAMENTS CONTAINING THESE PRODUCTS Roche Diagnostics GmbH (DE) 1991-08-14 EP disclosed
US-4730003-A Tricyclic compounds for treating heart and circulatory diseases BOEHRINGER MANNHEIM GMBH (DE) 1988-03-08 US disclosed
EP-0214592-A2 Pyrrolobenzimidazoles, process for their preparation and medicaments containing these products Roche Diagnostics GmbH (DE) 1987-03-18 EP disclosed